Stocklytics Platform
Asset logo for symbol FNA
Paragon 28
FNA56
$7.58arrow_drop_down0.13%-$0.01
Asset logo for symbol FNA
FNA56

$7.58

arrow_drop_down0.13%

AI Deep-Learning Forecast (FNA)

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Paragon 28 (FNA) Stocklytics Forecast

Paragon 28, Inc. (FNA) is a renowned medical device manufacturer, specializing in innovative solutions for foot and ankle surgeries. With their cutting-edge technology and commitment to excellence, Paragon 28 has established a strong presence in the market. Investors are often curious about the future prospects of the company, especially regarding its stock price.

When it comes to predicting the stock price of Paragon 28, Inc., various factors need to be considered. Traditional methods often fall short in providing accurate forecasts, but artificial intelligence (AI) and machine learning (ML) algorithms have shown great potential in this domain. Using AI and ML, analysts can generate reliable predictions for stock prices that enable investors to make well-informed decisions.

add Paragon 28 to watchlist

Keep an eye on Paragon 28

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is the analyst price prediction for Paragon 28 (FNA) stock?

Analysts have set a target price of $24.36 for Paragon 28 (FNA), based on forecasts from 14 analysts. The predicted price range extends from a high of $32 to a low of $14. This represents a potential increase of up to 322.16% and a decrease of 84.7% from the current price of $7.58. These forecasts are as of 2021 Nov 09.

help
What are the analyst ratings for Paragon 28 (FNA) stock?

Currently, there are no analyst ratings available for Paragon 28 (FNA), possibly due to insufficient coverage or recent updates.

help
What is the AI price prediction for Paragon 28 (FNA) stock?

At present, there is no AI or machine-learning-based price prediction available for Paragon 28 (FNA) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level